Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer. - Suppr | 超能文献

Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer.

作者信息

Corso G, Bonanni B, Veronesi P, Galimberti V

机构信息

Division of Breast Cancer Surgery, European Institute of Oncology, Via G. Ripamonti 435, 20141, Milan, Italy.

Division of Cancer Prevention and Genetics, European Institute of Oncology, Via G. Ripamonti 435, 20141, Milan, Italy.

出版信息

Arch Gynecol Obstet. 2018 Apr;297(4):1067-1068. doi: 10.1007/s00404-018-4705-9. Epub 2018 Feb 3.

DOI:10.1007/s00404-018-4705-9

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer.

Arch Gynecol Obstet. 2018 Apr;297(4):1067-1068. doi: 10.1007/s00404-018-4705-9. Epub 2018 Feb 3.

2

Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?

Eur J Surg Oncol. 2019 Oct;45(10):1760-1761. doi: 10.1016/j.ejso.2019.07.020. Epub 2019 Jul 19.

3

Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.CDH1 种系突变患者中遗传性弥漫性胃癌检测标准和结果的准确性。

Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.

4

CDH1 germline mutations and hereditary lobular breast cancer.CDH1基因种系突变与遗传性小叶乳腺癌

Fam Cancer. 2016 Apr;15(2):215-9. doi: 10.1007/s10689-016-9869-5.

5

Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations.与E-钙黏蛋白种系突变相关的遗传性小叶乳腺癌的临床标准修订

Per Med. 2018 May 1;15(3):153-155. doi: 10.2217/pme-2017-0083. Epub 2018 May 10.

6

Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.对胃癌家族进行E-钙黏蛋白筛查发现，仅在遗传性弥漫性胃癌家系中存在胚系突变。

Hum Mutat. 2002 May;19(5):510-7. doi: 10.1002/humu.10068.

7

Prognosis and outcome in CDH1-mutant lobular breast cancer.CDH1突变型小叶乳腺癌的预后与结局

Eur J Cancer Prev. 2018 May;27(3):237-238. doi: 10.1097/CEJ.0000000000000405.

8

Risk-reducing mastectomy in germline CDH1 mutation carriers: Pathologic findings.

Breast J. 2020 Mar;26(3):583-584. doi: 10.1111/tbj.13604. Epub 2019 Sep 20.

9

E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.E-钙黏蛋白（CDH1）和p53而非SMAD4和半胱天冬酶-10种系突变导致葡萄牙胃癌患者的遗传易感性。

Eur J Cancer. 2004 Aug;40(12):1897-903. doi: 10.1016/j.ejca.2004.04.027.

10

A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?BRCA 胚系突变携带者的乳腺癌和卵巢癌中 BRCA 启动子甲基化频率的系统评价：相互排斥，还是不排斥？

Crit Rev Oncol Hematol. 2018 Jul;127:29-41. doi: 10.1016/j.critrevonc.2018.05.008. Epub 2018 May 14.

引用本文的文献

1

A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.一项比较自我推荐信息与家庭推荐信息促进男性遵循 BRCA1/2 种系基因突变检测循证指南的依从性的随机对照试验：一项注册研究方案。

PLoS One. 2022 Apr 8;17(4):e0266327. doi: 10.1371/journal.pone.0266327. eCollection 2022.

2

Frequency of Germline Mutations in Non-Gastric Cancers.非胃癌中种系突变的频率

Cancers (Basel). 2021 May 12;13(10):2321. doi: 10.3390/cancers13102321.